Aytu BioPharma Inc. (AYTU)
NASDAQ: AYTU
· Real-Time Price · USD
1.78
0.00 (0.00%)
At close: Jun 02, 2025, 2:26 PM
0.00% (1D)
| Bid | 1.78 |
| Market Cap | 10.99M |
| Revenue (ttm) | 69.22M |
| Net Income (ttm) | 1.64M |
| EPS (ttm) | -1.46 |
| PE Ratio (ttm) | -1.22 |
| Forward PE | 1.36 |
| Analyst | n/a |
| Ask | 1.8 |
| Volume | 77,773 |
| Avg. Volume (20D) | 1,201,103 |
| Open | 1.75 |
| Previous Close | 1.78 |
| Day's Range | 1.78 - 1.81 |
| 52-Week Range | 0.95 - 3.23 |
| Beta | -0.10 |
About AYTU
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol AYTU
Website n/a
2 weeks ago
+91.85%
Aytu BioPharma shares are trading higher after the...
Unlock content with
Pro Subscription
2 weeks ago
+3.05%
Aytu BioPharma shares are trading higher after the company reported Q3 financial results and beat its EPS and revenue estimates.
2 weeks ago · accessnewswire.com
Aytu BioPharma Reports Fiscal 2025 Third Quarter Operational and Financial ResultsNet income of $4.0 million, or $0.65 and $0.21 net income per share basic and diluted, respectively Adjusted EBITDA1 of $3.9 million Total net revenue of $18.5 million up 32% year-over-year Company to...
1 month ago · accessnewswire.com
Aytu BioPharma to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025Company to conduct 1x1 meetings on April 24, 2025 DENVER, CO / ACCESS Newswire / April 21, 2025 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on comm...